Clinical Value of Serum Apolipoprotein A-1( Apo A-1 ) Detection in HBV-related Liver Cancer

Objective To investigate the clinical value of serum apolipoprotein A-1( Apo A-1) detection in HBV-related liver cancer. Methods Totally 362 cases of patients with chronic HBV infection were enrolled from January 2010 to December 2014 in our hospital,including 88 cases of chronic hepatitis B,94 cases of HBV-related liver cirhosis,18 cases of HBV-related liver cancer( without cirrhosis) and 162 cases of liver cirrhosis merged cancer. At the same time,45 cases of healthy people were selected for normal control.The serum Apo A-1,AFP and other laboratory markers were detected,and the test results were statistically analyzed. Results The difference of Serum Apo A-1 and AFP levels in all groups was statistically significant( F = 29. 86,χ~2= 112. 53,P = 0. 000). As the disease progressed,the serum levels of Apo A-1 gradually decreased( P 0. 05). The liver cancer patients with Child-Pugh score A,B,C had different serum Apo A-1 levels( all P < 0. 05); The serum Apo A-1 level of liver cancer patients with Child-Pugh score A was significantly higher than that of liver cirrhosis( t =-3. 02,P = 0. 003),but the differences of serum Apo A-1 levels between liver cancer and liver cirrhosis patients with Child-Pugh score B and C were not statistically significant( t = 0. 52,1. 19,P =0. 610,0. 240). The serum Apo A-1 levels of liver cancer patients with TNM stage Ⅰ and Ⅱwere significantly higher than those with TNM stage Ⅲ and Ⅳ( t = 3. 85,P < 0. 001). Conclusion The serum Apo A-1 levels of HBV-related liver cancer patients are related with cirrhosis,Child-Pugh score and TNM stage,and the liver reserve function,the body’ s stress response and many other factors may contribute to the expression of serum Apo A-1.